Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort StudyLisa Smits, Frank Hoentjen, Joost P.H. Drenth et al.|Journal of Crohn s and Colitis|2016Cited by 140